Haematology Flashcards

1
Q

what are the findings on Hb electrophoresis for

sickle cell
B thalassaemia trait
B thalassaemia major
a thalassamia trait

A

sickle cell - HbS present

B thalassaemia trait - HbA2 increased

B thalassaemia major - HbF present

a thalassamia trait - normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the normal Hb ranges in paeds?

A

o Neonate <140g/K
- anaemian is if its 90g/L

o 1 month → 1 year <100g/L
o 1 year → 12 year <110g/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does G6PD disease present?

pattern of inhertiance? epidemiology?

rx: avoid triggers

A

Common/ High prevalence (10–20%) in: meditarranean, middle eastern, Far East, Central African

X-linked

Triggered by; Infection, Fava beans, Napthalene,
Drugs (antimalarials, antibiotics, high dose aspirin)

Neonatal jaundice
Intermittent intravascular haemolysis
+ Fever, malaise
Dark urine, splenomegaly

Rx: avoid triggers, treat jaundice
• Folic acid supp
± transfusions rarely required ± splenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What would ivx show in G6PD disease?

A
  • Definitive diagnosis by measuring G6PD enzyme activity in RBCs
  • Also ↑reticulocyte count, macrocytosis
    • Heinz bodies, bite cells
  • Pts have normal blood picture between episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the aetiology, presentation and mx of Phenylketonuria?

A
  • Either a deficiency of phenylalanine hydroxylase (classic PKU)* that leads to LESS breakdown of amino acid phenylalanine = build up to toxic levels.
  • If untreated → present with developmental delay at 6-12 months. intellectual disability, seizures, behavioral problems, and mental disorders.

Musty odour due to phenylacetic acid metabolite

  • RF: fair-haired, blue eyed, eczema and seizures
  • Treatment: restrict dietary phenylalanine (lifelong) and monitor blood plasma levels regularly
  • enzyme supplements
  • nutrition supplements
  • or in synthesis or recycling of its biopterin cofactor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some of the dietary measures in PKU?

A

The diet requires restricting or eliminating foods high in Phe, such as soybeans, egg whites, shrimp, chicken breast, spirulina, watercress, fish, nuts, crayfish, lobster, tuna, turkey, legumes, and lowfat cottage cheese.

Starchy foods, such as potatoes and corn are generally acceptable in controlled amounts

FDA has approved an enzyme substitute called pegvaliase which metabolizes phenylalanine. It is for adults who are poorly managed on other treatments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the aetiology, presentation and mx of MCADD?

A
  • Auto recessive disorder of fatty acid metabolism
  • Unable to metabolise fatty acids beyond medium chain and into acetyl-CoA

• Gluconeogenesis is inhibited – body cannot metabolise fat

The disorder is characterized by hypoglycemia and sudden death without timely intervention, most often brought on by periods of fasting or vomiting.

Vomiting, lethargy, seizures = classic

Coma and hypoketotic hypoglycemia, often triggered by minor infection

Can present with liver disease - hepatomegaly
Common cause of SIDS (<2y) (preceded by minor illness)
• metabolic acidosis

Ivx:
• Guthrie
• Low glucose in response to fasting

  • Urinalysis – +ve medium-chain dicarboxylic aciduria and absent ketones
  • Mass spectrometry - lots of medium-chain acids
  • Management → avoid long periods not eating/fasting, high calorie diet, daily carnitine supplements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is homocystinuria?

aetiology and presentation?

A

A metabolic disorder that stops the body from breaking down the amino acid Homocysteine due to deficiency of cystathionine synthetase deficiency

Caused by gene mutations - Autosomal recessive

Inability to break down homocysteine = toxic build up and Nervous system damage

Presentation:
Children may have mild sx but worsens with age
Weak bones,
Tall & long thin arms n legs (Marfanoid appearance)
Near sightedness / diminished visual acuity
Spine curvature (scoliosis) + osteoporosis
Pale skin + hair
chest deformity

Developmental delay
slow weight gain
Progressive learning difficulty, psych disorders and Seizures/convulsions
thromboembolic episodes: strroke/MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is homocystinuria ivx ?

A

Ivx:
In-utero - amniocentesis (if FH)
Physical exam - long fingers etc
Paeds ophtal referral - Eye exam - Disclocated eye lenses (subluxation of lens) - later

Labs:
Increased serum and urine homocysteine and methionine levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is homocystinuria treated and the prognosis ?

A

Mx:
1. 50% respond to high dose of co-enzyme pyridoxine (vit B6)

  1. If not;
    A. treat with low-methionine diet (no eggs, soy, dairy, nuts and dairy)
    B. supplements with cysteine and folate (+betaine)
    C. Babies will need special formula, + small amount of breastmilk
  2. Psych input as they may feel left out eg at parties etc

Prognosis if Untreated:
75% die by 30 from - thrombotic complications eg MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is MAPLE SYRUP URINE DISEASE?

aetiology and presentation?

A
  • Autosomal-recessive, mutation in more than 3 genes
  • Loss of alpha-keto acid dehydrogenase

→ inability to breakdown some branched-chain amino acids – leucine, isoleucine, valine

  • Leading to accumulation of amino acids -> encephalopathy and progressive neurodegeneration
  • Maple syrup odor in cerumen (earwax) at 12-24 hours after birth

• Poor feeding, vomiting, poor weight gain, neuro signs

  • Sleepiness, irritable
  • coma, brain damage (late)
  • Ketosis and maple syrup odor of urine

• Developmental + psychomotor delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is MAPLE SYRUP URINE DISEASE?

ivx and mx?

A

IX:
• Ketonuria
• Increased branched chain amino acids in plasma
• Increased urine pyruvate, lactate, BCAAs
mehtylvaleric acid present

Management:
• Dietary leucine restriction - proteins, dairy restriction
• Limited breast milk

  • High calories BCAA-free formula - contains nutrients they need to live
  • Thiamine supplements

• Careful supplements with isoleucine and valine - as needed for growth

  • Frequent growth + development checks and blood tests
  • +/- liver transplant or haemodialysis - if serious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the aetiology, presentation and mx of ISOVALERIC ACIDEMIA

A
  • Body cannot catabolise leucine into isovaleric acid
  • Leads to buildup of leucine in blood and urine

• they smell like sweaty feet

decreased feeding, decreased weight, lethargy and metabolic crisis

lack of energy
vomiting
irritability
breathing difficulties

• Treat with low protein diet with decreased leucine

Supplements: L-carnitine or glycine - can be given especially in acute episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which metabolic disorder may present with

macrocephaly, hypotonia, increased risk of subdural, metabolic crisis?

A

GLUTARIC ACIDURIA type 1

Treat with low protein diet and L-carnitine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the treatment options for iron deficiency in kids?

A

Defined as Once Hb is <6-7g/dl

Usually give as Oral solutions:
Sodium Feredetate - market name Sytron

Ironorm drops

Take until normal Hb, then continue for a minimum of 3 months after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what will ivx show in Haemophilia?

A

APTT: prolonged

if so order:
1. Mixing studies - will come out normal

Factor 8/9 assay : severity based on amount of factor present/absent
PT: Normal
Bleeding time: normal
X-ray joint - if suspecting haemarthrosis

others:
vWD assay - normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do we mx haemophilia?

A

Prophylactic:

Mild Haemophilia A
1st • Desmopressin for (stimulates F8 and VWF release) + Tranexamic acid

Severe HA (eg the get spontaneous bleeding):
1st • Prophylactic injection of factor 8 replacement - give these 3 times a week or more depending on severity

Mild Haemophilia B
1st - Prophylactic factor 9 replacement until sx stopped
+ Tranexamic acid

Central venous access device (implantable port) – allows factor replacement to be done at home

If actively bleeding:

o Prompt IV infusion with F8/9 concentrate
o Raising circulating factor level to 30% normal is enough to treat minor bleeds or simple joint bleeds
o Major/life-threatening bleeds require 100% → then maintain at 30% for 2 weeks to prevent 2ndary haemorrhage – give as a regular/continuous infusion

+ Analgesia (paracetamol or codeine) - no nsaids!!

MDT: Physio, Ortho

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are inhibitors in Haemophilia?

A

when patients have been infusion factor for a while,

the body can manufacture inhibitors which serve to break down the injected factor concentrate really quickly.

when these inhibitors are present, we must take this into account for the management:

Give Bypassing agents including recombinant factor VIIa or factor VIII inhibitor bypassing fraction INSTEAD of normal factor infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Whta is the aetiology and presentatoin of IDIOPATHIC THROMBOCYTOPENIC PURPURA - ITP

A

Aka Immune TP
Usually destruction of platelets by anti-platelet IgG autoantibodies
• Most common cause of childhood thrombocytopenia

Acute form:
• 2-10y, onset often 2 weeks post-viral infection
• Short history (days or weeks)
o Petechiae
o Purpura
o ± superficial bruising
o Menorrhagia
  • Can cause epistaxis or mucosal bleeding but profuse bleeding is uncommon
  • Intracranial bleeding is a rare but severe complication

Chronic form:

  • sx last 6 months -> years
  • more common in adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what do ivx show in ITP?

A

Dx of exclusion

Bloods:
Low Platelet count <150x109/L
      - In chronic ITP - still low 6 months after diagnosis
Blood film
Possible increase in megakaryocytes

atypical clinical features (Anaemia, neutropenia, hepatosplenomegaly, marked lymphadenopathy) should prompt a bone marrow examination to exclude acute leukaemia or aplastic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do we mx ITP?

A
  • In 80% children, disease is acute, benign and self-limiting, usually remitting spontaneously within 6-8 weeks
  • If major bleeding or persistent minor bleeding →
  1. Prednisolone,
    2.IVIG - works faster than pred (24hrs)
    Others:
  2. IV anti-D (Rh) - stops spleen from destoyinf platelets - must be Rh +ve

• Advise child to avoid trauma/contact sports whilst recovering

Chronic:
Supportive care, Rituximab (allows antiplatelt antibodies to be made), Splenectomy (stop pooling and destruction of platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how does leukaemia present?

A
  • Peak at 2-5 years
  • Insidious presentation – malaise, anorexia, night sweats
  • BM infiltration → anaemia (pallor), neutropenia (infection), thrombocytopenia (bruising, petechiae, epistaxis), bone pain
  • Reticulo-endothelial infiltration → hepatosplenomegaly
  • Other organ infiltration (usually with relapse) → CNS → headache, nausea, vomiting, nerve palsies, testicular enlargement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how would you ivx leukaemia?

A

• FBC → decreased Hb, thrombocytopenia, evidence of circulating leukaemic blast cells, increased LDH

  • Clotting → +/- DIC
  • Check LFTs and U&Es (renal function) before chemo

• BM aspiration and biopsy → essential to confirm diagnosis
o More than 20% blasts in BM or peripheral blood
o ID immunological and cytogenic characteristics to give prognostic info – identify translocations

• Immunological phenotyping → to further subclassify ALL
o Common (75%)
o T cell (15%)

• CXR to identify mediastinal masses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is invovled in the mx of leukaemia?

Prognosis?

A

Chemotherapy

  1. Induction Phase
    - > Inpatient – hospital or specialist centre
    - > Chemotherapy
    i. Vincristine
    ii. Corticosteroids (dex)
    iii. Anthracyclines
    iv. +/- cyclophosphamide/cytarabone
  2. Consolidation – outpatient (months)
  3. Maintenance – chemo tablets – last 2-3 years
    a. Usually daily 6-mercaptopurine and weekly methotrexate
    +/- ABX and antifungals as infection prophylaxis
    +/- steroids
    +/- allopurinol as increased uric acid levels
  1. If Philadelphia +ve ALL → give Imatinib
  2. Radiotherapy used if spread to CNS or to prepare before BM transplant
  3. +/- stem cell transplant if no response to chemo or radio (in CNS disease)

• 80-90% completely cured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

how would we ivx hodgkins and what would we see?

A

• Lymphadenopathy, hepatosplenomegaly, SVC syndrome

• Bloods
o FBC, ESR, LFT, LDH, Alb – prognostic indicators
-low Hb n platelets if bone marrow involvement
- ESR high

• CXR – check for intrathoracic lymphadenopathy, mediastinal expansion
-> mediastinal mass usually seen (adenopathy) - indicates poor prognosis

  • Lymph node biopsy – excisional, look for Reed-Sternberg cells
  • Radiological assessment of all nodes – FDG PET-CT scan – stage
  • BM biopsy – for staging - no point if low stage as unlikely to involve BM

Classification → classical (95%) and nodular lymphocyte predominant (NLPHL)

26
Q

what is the mx principle for Hodgkin?

Prognosis?

A

• Combination chemo +/- radiotherapy
o ABVD

+/- recombinant human granulocyte colony-stimulating factor (RHG-CSF)

PET to monitor treatment response

• 80% can be cured
• Risk of long term problems
o Infertility – review with fertility specialist
o Hypothyroid (radio)
o Development of other cancers

Regular F/U for 2-5 years

Lymphoma action - support groups
Macmillan

27
Q

how may non-hodgkin lymphoma NHL present?

A

• NHL is 5x more common than Hodgkin’s

• T cell malignancies can present as ALL or NHL

Both characterised by mediastinal mass

• High grade lymphoblastic and noncleaved lymphomas – most common in children,

 Clinically:
• Low grade
o Painless
o Slow progressing lymphadenopathy
o BM involvement
o Hepatosplenomegaly

• High grade
o Rapidly growing, bulky lymphadenopathy
o More systemic and extranodal involvement
o Abdo pain and palpable mass – due to intestinal obstruction or intussusception + hepatosplenomegaly
o Skin lesions, testicular mass
o Lymphoblastic lymphoma → mediastinal mass, SVC syndrome, CN palsies
o Burkitt’s → abdo mass and bowel obstruction

28
Q

how do we ivx non-hodgkin lymphoma NHL?

A

• FBC, LFT, LDH
serology (hep C, HIV), renal function, U&E, cytogenics (Burkitt’s)
- thrombocytopenia, pancytopenia, lymphocytosis
- nucleated red blood cells, left shift
- LFT - high
- LDH - high (bad prognosis)

  • Biopsy- SKIN (eg cutaneous T cell), BONE
  • CT scan for staging, examination of BM and CSF
29
Q

principles of NHL mx? prognosis?

A

o Treatment options vary with different forms
o Ensure vaccines are UTD and give extras – Men C, HIB

1• Multimodal chemo
• Abx prophylaxis +/- rhg-CSF
• Chemo options – CHOP-R
o Cyclophosphamide, doxorubicin, vincristine, prednisolone, rituximab

  • Primary CNS lymphoma – high dose methotrexate and dexamethasone
  • Survival rates over 80%
30
Q

characterise Burkitts?

A

Type of B-cell NHL,
Most commonly in children living in malaria endemic regions

Most common childhood cancer in Africa

Immunocompromised; HIV

EBV seen in most

31
Q

what is the aetiology and presentation of OSTEOSARCOMA?

A

• Most common primary bone malignancy in children

Mesenchymal cells producing osteoid and immature bone

• Occurs in metaphysis of long bones – 75% in KNEE

Most common cancer following radiation/radiotherapy

Clinically:
- Usually teenagers

  • Mild bone pain (eg knee pain) that becomes increasingly severe, usually of several months’ duration
  • Limp
  • Deep pain, unremitting
  • Mass/swelling - follows pain -> restricted movement

• Destroys bone and spreads to surrounding tissue
-> could present with fracture - osteolytic tumour

• Rapid mets to lung

32
Q

how do we ivx osteosarcoma?

A
  • XR → radiolucent lesion, with areas of radiodensity -> combination of bone destruction and formation
  • Soft tissue calcification = sunburst appearance

Serum ALP, LDH - High

  • Biopsy of tumour site
  • Imaging of tumour site:

CT - dense bony mass; may show central calcification, cortical destruction
FDG-PET: intensely hot signal at primary tumour site;

33
Q

principles of mx of Osteosarcoma? prognosis?

A

• Transfer to specialised sarcoma team (London)

1• Surgery - resection of primary tumour and bone reconstruction

Adjunct:
Chemo - not needed if mild
Radiotherapy - only needed if metastatic disease

  • Limb sparing surgery v amputation considered - studies show no difference in survival
  • Disease free survival at 75% to 80%
• Post treatment:
o OT, PT
o Dietician
o Orthotics/prosthetics
• Support → Sarcoma UK
34
Q

what is the aetiology and presentation of Ewings Sarcoma?

A

may be a bone sarcoma or a soft-tissue sarcoma.
Often genetic, due to translocation

Bone pain, particularly occuring at night
A mass or swelling
Restricted movement in a joint

pelvis + femur + tibia, ribs and shoulder blade most common, but also:
Long bones of arms, skull, trunk

• + pain, redness around tumour, malaise, fever,
paralysis/ incontinence if in the spinal region

can present with fracture

35
Q

how do we ivx Ewings?

A

Biopsy + PAS staining -small-blue-round-cell tumor that typically has a clear cytoplasm on H&E staining

Its a high grade cancer

  • XR shows bone destruction with overlying onion-skin layers of periosteal bone formation
  • CT/MRI/PET to assess extent of spread
36
Q

principles of mx of Ewings sarcoma? prognosis?

A

• Chemotherapy (VIDE) - before surgery

+/- radiotherapy (main option if cant operate eg spinal tumour)

• Surgery to remove tumour – limb sparing v amputation

  • Survival 60-70% for localised tumours
  • 20-40% for mets

• Post treatment
- regular check ups and X-rays
o OT, PT, dietician, orthotics/prosthetics

37
Q

How would you explain sickle cell and crisis to patients?

A
  • Sickle cell disease is the collective name given to haemoglobinpathies in which HbS is inherited.
  • HbS forms as a result of a point mutation in codon 6 of the β-globin gene, which causes a change in the amino acid encoded from glutamine → valine
• Sickling is exacerbated by
o Reduced O2 tension, cold,
• Sickled cells have a reduced lifespan
• Can get trapped in the microcirculation → vaso-
occlusion → ischemia in bone or organs
38
Q

What are the pheno and genotypes in sickle cell disease?

A
• Sickle cell anaemia (HbSS)
o Homozygous
o No HbA
o Almost all HbSS with some HbF, no normal β-globin genes
Full blown disease
• HbSC
o One HbS from one parent
o One HbC (different point mutation)
o No HbA, no normal β globin genes 
Mild disease
• Sickle β-thalassemia
o HbS from one parent
o β-thal trait from other
o no normal β globin genes – similar to above two
Mild disease

• Sickle trait
o Inheritance of HbS from one, normal β globin gene from other → asymptomatic

39
Q

what is the clinical presentation of sickle cell disease?

A
  • Anaemia ± jaundice from chronic haemolysis
  • Infection - ↑ susceptibility from encapsulated organisms, ↑ incidence of osteomyelitis, due to hyposplenism
  • Painful crisis → vaso-occlusive eg. hand-foot syndrome with dactylitis and swelling and pain of hands and feet
  • Growth: short stature, delayed puberty,
  • Brain: stroke, cognitive issues,
  • Enlargements: adenotonsillar hypertrophy, cardiac enlargement and HF (chronic anaemia),
  • Organs: renal dysfunction, gallstones, psychosocial
  • Priapism → risk of fibrosis of corpora cavernosa → impotence
  • Splenomegaly – common in young children

• Acute anaemia → sudden drop in Hb from haemolytic crisis, aplastic crisis (parvovirus), sequestration crisis (accumulation in spleen – sudden hepato/splenomegaly, abdo pain)

40
Q

hwo do we ivx sickle cell?

A

• DNA based assay
• Hb isoelecric focusing
• Hb electrophoresis, FBC, reticulocyte count
——
Outcome:
Newborns: fetal HbF will predominate; in older infants, the amount of HbS will increase as HbF decreases; by 2 years of age the amount of HbS and HbF stabilises; patients with sickle cell anaemia will have no HbA
——-
• Peripheral blood film – sickled cells, nucleated RBCs, Howell-Joly bodies

CXray + spirometry if acute chest
O2 sats
Blood cultures - if suspecting infection
Xray long bones - if suspecting bone infection

41
Q

how do we manage an acute sickle crisis?

A

• Acute crisis → admit to hospital
o Oral/IV analgesia (avoid morphine < 12 years)
o fluids PO/IV
o O2 - if low sats
o Exchange transfusion is indicated for acute chest syndrome, priapism and stroke - replacing blood withh donor blood

o IV broad spectrum Abx - if acute chest
o TX infection with ABX, give O2 if required
o Correct triggers – acidosis or cold

42
Q

how do we manage long term sickle cell disease?

A

If recurrent hospital admission (>3 in 12 months) for acute chest syndrome or vaso-occlusive crises:
-> Hydroxycarbamide (stimulated HbF production)

43
Q

how does acute chest syndrome present in SCD?

AETIOLOGY?

A

defined as a new radiodensity on chest radiograph accompanied by fever and/or respiratory symptoms:

chest pain, cough, fever, hypoxia (low oxygen level), tachypneoa, and lung infiltrates.

kids may also have abdo pain - referred

Acute chest syndrome may be the result of sickling in the small blood vessels in the lungs causing a pulmonary infarction/emboli or viral or bacterial pneumonia

44
Q

What cause hyposplenism in SCD?

A

sickling of blood cells in splenic microvasculature -> splenic infarction = hyposplenism

Hyposplenism increases the susceptibility to infection with encapsulated bacteria (e.g. S. pneumoniae and H. influenzae type B), which is notably reduced by penicillin prophylaxis

also seen in coeliac disease

45
Q

what is the prognosis of SCD?

A

Can cause premature death due to complications

50% of patients with the most severe form of sickle cell disease will die < 40 years

46
Q

The following resutls is indicative of what?

HbA +ve
HbA2 +ve
HbF +ve increased
HbS +ve

A

sickle trait

with scd, there is NO HbA

47
Q

what are the genotypes in B thalassaemia ?

A

mutations of the β-globulin gene leading to decreased or absent synthesis of β-globin

  • β-thalassemia major → minimal to no HbA (α2β2), elevated HbF + HbA2
  • β-thalassemia intermedia → decreased HbA, elevated HbF + HbA2
  • β-thalassemia trait → mostly HbA, elevated HbF and HbA2
48
Q

how does b thal present?

A

• Severe anaemia → transfusion dependent from 3-6 months of age
o + jaundice, FTT/growth failure, pallor

• Extramedullary haematopoiesis → hepatosplenomegaly (abdo distension), BM expansion, maxillary overgrowth, skull bossing, “chipmunk facies”, misaligned teeth

49
Q

what ivx would we do in b thal?

A
  • FBC
  • Peripheral blood smear (microcytic red cells, tear drops, microspherocytes, target cells, fragments, large number of nucleated red cells)
  • Reticulocyte count - elevated
  • Hb analysis
  • LFTs - high bilirubin and LDH
  • Skull XR, Abdo XR
50
Q

how do we mx B thal?

A

B thal major:
• Regular blood transfusion → required for survival
• Lifelong, monthly red cell transfusions
• Aim to keep Hb > 20g/dl to reduce complications
- Iron monitoring + chelation
- Adjunct: splenectomy

B thal trait:
• Iron pills if deficient + genetic counselling (to all)

B thal intermedia;
May be transfusion dependent/independent
if independent: transfusion only with symptomatic anaemia

Complications:
• Repeated transfusions → iron overload and ↑ iron deposition in tissues → cardiac failure, liver

51
Q

what is the aetiology of vWD?

A

Von Willebrand disease (VWD) is the most common hereditary blood-clotting disorder in humans.

An acquired form can sometimes result from other medical conditions.

It arises from a deficiency in the quality or quantity of von Willebrand factor (VWF), a multimeric protein that is required for platelet adhesion

52
Q

how does vwd present?

A

easy bruising, nosebleeds, and bleeding gums

Women experience heavy menstrual periods and excess blood loss during childbirth - significant imapct on QoL!

Severe internal bleeding and bleeding into joints are uncommon in all but the most severe type, VWD type 3.

affects areas with extensive small vessles eg skin

53
Q

what are the genotypes in vWD?

A

Type 1 - quantitative vwf defect. Auto Dominant

Type 2 - qualitative vwf defect. Mixed Dom/Recessive

Type 3 - complete absence of vwf production. Auto recessive

Milder forms are much more common than severe forms

54
Q

how do we manage von willibrand? vWD?

A

• Depends on type and severity

1 • Type 1 vWD can be treated with Desmopressin (DDAVP)

o NOTE: it should be used with caution in children < 1 year old, because it can cause hyponatraemia and may precipitate seizures

2 • More severe types of vWD have to be treated with plasma-derived factor 8 concentrate

• Things to AVOID in vWD:
o IM injections
o Aspirin
o NSAIDs

55
Q

How long does it take for HbF to decrease in neonates?

A

Fetal haemoglobin (HbF) constitutes around 60%–80% of total Hb in the newborn;

values decline postnatally to 2% of total Hb at 6–12 months.

56
Q

what are the poor prognositc markers in ALL?

A

White cell count > 50 × 10 9 g/L at diagnosis
Age < 1 year
Age > 10 years
Minimal residual disease positive at 28 days
Slow response to therapy

MLL rearrangements
Central nervous system positive
	T-cell ALL
Testicular leukaemia	
Philadelphia chromosome positive
57
Q

what is neuroblastoma?

A

Neuroblastoma is a malignancy of neural crest cells that normally give rise to the paraspinal sympathetic ganglia and the adrenal medulla. It is the second most common solid tumour of childhood, occurring predominantly in infants and preschool children with a median age at diagnosis of 2 years. It is unusual in that it can regress spontaneously in very young children (stage IV-S). They can occur anywhere in the sympathetic nervous system but are most commonly found in the adrenals or abdomen.

58
Q

presentation of neuroblastoma?

A

the clinical features depend on the location and may include:

  • abdominal mass: a firm, nontender abdominal mass (common)
  • systemic signs: pallor, weight loss, bone pain from disseminated disease
  • hepatomegaly or lymph node enlargement
  • unilateral proptosis: metastasis to the eye
  • opsoclonus-myoclonus: ‘dancing-eye’ syndrome caused by an immune response.
  • diarrhoea: due to secretion of vasoactive intestinal peptide
  • respiratory distress: mediastinal mass (may also by incidentally detected on X-ray)
59
Q

dx and ivx of neuroblastoma?

A

Diagnosis may be suspected from characteristic clinical and radiological features (with calcium speckling of tumour). This is confirmed with:

  • Biopsy demonstrating classical features on light microscopy with or without immunological staining.
  • Raised urinary catecholamines (vanillylmandelic acid, homovanillic acid).
  • Meta-iodobenzylguanidine, a radiolabelled tumour-specific agent, or other nuclear scan such as fludeoxyglucose positron emission tomography–CT is useful to measure disease extent.
  • Bone marrow aspirates and trephines to detect infiltrative disease.
60
Q

rx of neuroblastoma?

A

Treatment of neuroblastoma includes:

  • surgical resection
  • chemotherapy
  • radiotherapy (especially for high-grade tumours and complications, e.g., spinal cord compression)

Prognosis is worse for older children and those with metastatic disease.

Overexpression of the N-myc oncogene in the tumour is associated with a poor prognosis.